Conversion from unresectable to resectable liver metastases in real-world patients with liver-only metastatic colorectal cancer (mCRC) treated with FOLFOXIRI plus bevacizumab: The Conversion trial.

Shahid Ahmed, Mike Moser, Haji Chalchal et al.|Journal of Clinical Oncology|2021

Cited by 2